This Article Full Text Full Text (PDF) All Versions of this Article: 90/8/4955    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ilias, I. Articles by Nieman, L. K. Search for Related Content PubMed PubMed Citation Articles by Ilias, I. Articles by Nieman, L. K. Related Collections Adrenal and Hypertension Endocrine Oncology

Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health

Pediatric and Reproductive Endocrinology Branch (I.I., D.J.T., K.P., L.K.N.), National Institute of Child Health and Human Development and Department of Nursing (N.M.) and Biostatistics and Clinical Epidemiology Service (R.A.W.), Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892-1109

Address all correspondence and requests for reprints to: Dr. Lynnette Nieman, Building 10, Clinical Research Center, 1 East, Room 1-3140, 10 Center Drive, MSC 1109, Bethesda Maryland 20892-1109. E-mail: niemanl{at}exchange.nih.gov.

Context: Ectopic ACTH secretion (EAS) is difficult to diagnose and treat. We present our experience with EAS from 1983 to 2004.

Setting: The study was performed at a tertiary care clinical research center.

Patients: Ninety patients, aged 8–72 yr, including 48 females were included in the study.

Interventions and Outcome Measures: Tests included 8 mg dexamethasone suppression, CRH stimulation, inferior petrosal sinus sampling (IPSS), computed tomography, octreotide scan, magnetic resonance imaging, and/or venous sampling. Therapies, pathological examinations, and survival were noted.

Results: Eighty-six to 94% of patients did not respond to CRH or dexamethasone suppression, whereas 66 of 67 had negative IPSS. To control hypercortisolism, 62 patients received medical treatment, and 33 had bilateral adrenalectomy. Imaging localized tumors in 67 of 90 patients. Surgery confirmed an ACTH-secreting tumor in 59 of 66 patients and cured 65%. Nonthymic carcinoids took longest to localize. Deaths included three of 35 with pulmonary carcinoid, two of five with thymic carcinoid, four of six with gastrinoma, two of 13 with neuroendocrine tumor, two of two with medullary thyroid cancer, one of five with pheochromocytoma, three of three with small-cell lung cancer, and two of 17 with occult tumor. Patients with other carcinoids and ethesioneuroblastoma are alive.

Conclusions: IPSS best identifies EAS. Initial failed localization is common and suggests pulmonary carcinoid. Although only 47% achieved cure, survival is good except in patients with small-cell lung cancer, medullary thyroid cancer, and gastrinoma.

This article has been cited by other articles:

				B. M. K. Biller, A. B. Grossman, P. M. Stewart, S. Melmed, X. Bertagna, J. Bertherat, M. Buchfelder, A. Colao, A. R. Hermus, L. J. Hofland, et al. Treatment of Adrenocorticotropin-Dependent Cushing's Syndrome: A Consensus Statement J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2454 - 2462. [Abstract] [Full Text] [PDF]

				P. A Cassier, S. Abou-Amara-Olivieri, P. Artru, M.-G. Lapalus, J.-P. Riou, and C. Lombard-Bohas Mifepristone for ectopic ACTH secretion in metastatic endocrine carcinomas: report of two cases. Eur. J. Endocrinol., June 1, 2008; 158(6): 935 - 938. [Abstract] [Full Text] [PDF]

				J R Meinardi, B H R Wolffenbuttel, and R P F Dullaart Cyclic Cushing's syndrome: a clinical challenge Eur. J. Endocrinol., September 1, 2007; 157(3): 245 - 254. [Abstract] [Full Text] [PDF]

				F Castinetti, I Morange, H Dufour, P Jaquet, B Conte-Devolx, N Girard, and T Brue Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing's syndrome Eur. J. Endocrinol., September 1, 2007; 157(3): 271 - 277. [Abstract] [Full Text] [PDF]

				S. G. Spiro, M. K. Gould, and G. L. Colice Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 149S - 160S. [Abstract] [Full Text] [PDF]

				L. R. Salgado, M. C. B V. Fragoso, M. Knoepfelmacher, M. C. Machado, S. Domenice, M. A. A. Pereira, and B. B. de Mendonca Ectopic ACTH syndrome: our experience with 25 cases. Eur. J. Endocrinol., November 1, 2006; 155(5): 725 - 733. [Abstract] [Full Text] [PDF]

				R.T. Netea-Maier, W.-A. Nieuwlaat, C.G.J. Sweep, P. Wesseling, L. Massuger, and A.R.M.M. Hermus Virilization due to ovarian androgen hypersecretion in a patient with ectopic adrenocorticotrophic hormone secretion caused by a carcinoid tumour: Case Report Hum. Reprod., October 1, 2006; 21(10): 2601 - 2605. [Abstract] [Full Text] [PDF]

				M. B. C C. Neto, M. C. Machado, F. Mesquita, N. R. de Castro Musolino, A. C. Toscanini, G. Ochman, V. A. S Cescato, R. Marino Jr, and M. J. Teixeira Thymus hyperplasia after resolution of hypercortisolism in ACTH-dependent Cushing's syndrome: the importance of thymic vein catheterization. Eur. J. Endocrinol., June 1, 2006; 154(6): 807 - 811. [Abstract] [Full Text] [PDF]

				A. M. Isidori, G. A. Kaltsas, C. Pozza, V. Frajese, J. Newell-Price, R. H. Reznek, P. J. Jenkins, J. P. Monson, A. B. Grossman, and G. M. Besser The Ectopic Adrenocorticotropin Syndrome: Clinical Features, Diagnosis, Management, and Long-Term Follow-Up J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 371 - 377. [Abstract] [Full Text] [PDF]